MBP-PTR1 did not change the viability of RPMI8226, MM.1S, and MM.1R cells in the absence of bortezomib, but it induced bortezomib resistance to these MM cells to variable degrees (Fig 8C–E). This evidence concerns the gene MBP and Miyoshi myopathy.